Future Care for Medical Industries (FCMI) results, Q2 2022
Net profit, assets, equity and cash flow for Q2 2022, against the same period a year earlier, from the published financial statements.
Net profit-37.81 thousandEGP · +79.4% vs the same period a year earlier
Total assets62.72 millionEGP · +81.1% vs the same period a year earlier
Shareholders' equity59.64 millionEGP · +127.4% vs the same period a year earlier
Operating cash flow-2.33 millionEGP · −1391.9% vs the same period a year earlier
In short
- Future Care for Medical Industries (FCMI)'s net profit for Q2 2022 was about -37.81 thousand EGP, up +79.4% from -184 thousand EGP in Q2 2021.
- Total assets at the end of Q2 2022 were about 62.72 million EGP, and shareholders' equity about 59.64 million EGP.
- Operating cash flow for Q2 2022 was negative at 2.33 million EGP.
Key lines against the same period a year earlier
This periodQ2 2021Change
Net profit-37.81 thousand-184 thousand+79.4%
Gross profit141 thousand117 thousand+20.6%
Total assets62.72 million34.63 million+81.1%
Total liabilities3.08 million8.41 million−63.4%
Shareholders' equity59.64 million26.23 million+127.4%
Total liabilities and equity62.72 million34.63 million+81.1%
Operating cash flow-2.33 million180 thousand−1391.9%
Investing cash flow-821 thousand——
Financing cash flow-453 thousand-188 thousand−141.7%
Net change in cash-3.6 million-7.51 thousand−47858.7%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Future Care for Medical Industries (FCMI)'s Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy